Capacidad de la procalcitonina para predecir bacteriemia en pacientes con neumonía adquirida en la comunidad
Agustín Julián-Jiménez(Complejo Hospitalario Universitario de Toledo), Pablo Gallardo Schall(Complejo Hospitalario Universitario de Toledo), Raquel Parejo Miguez, Manuel Flores Chacartegui(Complejo Hospitalario Universitario de Toledo), Jesús Timón Zapata(Complejo Hospitalario Universitario de Toledo), Emilio J. Laserna‐Mendieta(Hospital General de Tomelloso)
Cited by 24
Related Papers
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
|Nature Communications|2020|283
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study
|Gut|2020|249
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
|Alimentary Pharmacology & Therapeutics|2016|163
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry
|Alimentary Pharmacology & Therapeutics|2020|130